- Strong growth in Germany, additional contracts with health insurers, leading to its first year of operating and net profit.
- Significantly improved group financial performance, with EBITDA margins of over 20%.
- Strong balance sheet with significant cash reserves to support growth.
- World’s first wireless 12 Lead Digital Cellular personal ECG transmitter Cardio Sen’CTM receives FDA clearance.
Download the full report
